Has U.S. health care for the elderly become more equitable during the past several decades? When inequality is measured by Medicare expenditures, the answer is yes. During 1987-2001, low income households experienced an increase of 78 percent ($2624) in per capita expenditures, double the increase of 34 percent ($1214) in the highest income group. When inequality is measured by life expectancy, the answer is no. Survival for the lowest income decile grew by 0.2 years during the 1990s compared to 0.8 years in the highest income group. That the two measures deliver such discordant messages may reflect their intrinsic shortcomings; expenditures depend on preferences, health status, and prices, while outcomes are strongly affected by health behavior and past illness.
The technological revolution in health care has brought both great benefits with respect to survival and general well-being, and substantial increases in costs.
1 Whether these changes have reduced inequality in health care or in health outcomes is not well understood. Earlier research suggested that medical care innovations, such as the use of antibiotics in the treatment of tuberculosis, reduced health care disparities by race (McDermott, 1978) . On the other hand, studies of health care expenditures by income group found higher income groups accounting for a larger fraction of spending, particularly after accounting for health status. 2 Recent studies also suggest that better educated patients get access to newer drugs (Lleras-Muney and Lichtenberg, 2002) , survive longer following the diagnosis of cancer (Glied and Lleras-Muney, 2003 ) and comply better with regimens for the treatment of AIDS (Goldman and Smith, 2002) .
This paper returns to the question of whether technological advances and increases in health care expenditures have been associated with a widening or a narrowing of inequality in health or in health care. The group studied is the over-65 population in the United States during the 1990s, which is of interest given their high rates of utilization and very high rates of insurance coverage under the Medicare program. Initially, two conventional measures of inequality are considered: health care
expenditures and health care outcomes as measured by 10-year survival rates. Using 1 Cutler et. al. (1998) , Cutler and McClellan (2001) , Cutler (2004) , Skinner, Staiger, and Fisher (2004) .
detailed Medicare claims data on a panel of several million people in the over-65 population in the United States back to 1987, we matched individuals to income deciles based on median income in their zip code of residence. Between 1987 and 2001, we found a dramatic increase in health care expenditures among the lowest income groups, accounting for a 78 percent increase ($2624) in real terms compared to a 34 percent increase ($1214) for those in the top income decile. Using expenditures as a marker for health inequality, one would conclude that inequality has lessened, and if anything the higher (annual) expenditures for lower income households would help to compensate for earlier years during which insurance coverage and preventive care was minimal.
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There are a variety of disadvantages to using expenditures for health care as a measure of access, however. Expenditures may reflect patient preferences, health status, and access to care, nor is it clear how expenditures on health care translate into health outcomes (e.g., Fisher et. al., 2003a,b) . For example, much of the differential increase in expenditures by income group during this period was accounted for by home health care, a program where 40 cents of every dollar in spending was deemed inappropriate by one government investigation (Havemann, 1997) .
A different picture emerges in the evolution of outcomes as measured by 10-year survival rates. While each income group experienced a survival gain during the 1990s, those in higher income groups did better: life expectancy rose by 0.2 years in the bottom income decile compares to 0.8 years in the top income decile. But this measure is not immune from criticism either. Individual decisions regarding healthy behavior exert an important influence on health outcomes over the life-course, and it is rarely clear whether these choices should be attributed to "preferences," education, or economic status per se (Graham, 2002; Contoyannis and Jones, 2004; Smith, 2003) . As well, long and variable lags in outcomes make it difficult to evaluate the impact of the current health care
expenditures on changes in current health outcomes, particularly when income itself is endogenous to health status (Case and Deaton, 2003) .
That the two measures of health inequality are contradictory suggest the need for a different approach. We propose focusing on a more limited set of effective (or highquality) utilization measures with well-established benefits. 4 These measures include mammography screening among women age 65-69, eye examinations for diabetics, and smoking cessation advice, aspirin, -blockers, and reperfusion in the first 12 hours following the heart attack. These latter three treatments accounted for the vast majority of improvement in 30-day survival following heart attacks (Heidenreich and McClellan, 2001 ). The advantage of these measures over expenditures is that one need not control for health status; nearly everyone in the appropriate universe should be receiving these treatments. Nor does one need to control for preferences towards health care, or for lifestyle differences; every appropriate heart attack patient should be receivingBlockers upon admission, regardless of whether they are marathon runners or couch potatoes. 5 The use of these measures are not dependent on genetic or environmental factors that might further confound differences in survival rates across income groups.
As well, there is increasing effort to collect these measures as components of health care quality indices, for example by the National Committee for Quality Assurance (NCQA) at the hospital level or by Jencks (2003) at the state level. 4 This terminology follows that in Wennberg et. al. (2002) . 5 In some cases, preferences can still play a role in screening programs, see Walter et. al. (2004 6 Reperfusion therapy (12-hour surgical angioplasty or "clot busting" thrombolytics) is effective at removing the blockage or clots restricting blood flow to the heart. Aspirin is effective at breaking down platelets that are essential components of these clots interfering with blood flow. ACE inhibitors attenuate the body's natural tendency to constrict vascular walls, while blockers reduce the body's demands on the heart.
The Measurement of Health and Health Care Inequality
It is important to distinguish between inequality in health care and inequality in health. There is a long history of measuring inequality in health care by the use of utilization or expenditures measures. Le Grand (1978 and others found a positive gradient between expenditures and income after controlling for measures of health status in the United Kingdom, even after several decades of National Health Insurance. While there was a lively debate about how best to measure income-based gradients in health care ( Wagstaff et. al., 1991 , Le Grand, 1991 , the positive association between expenditures and income has been found in many countries with just a few exceptions (Wagstaff et. al., 1991) . The earlier evidence from the United States pointed towards the same positive association between expenditures and income (Davis and Reynolds, 1975; Link, Long, and Settle, 1982) , although more recent data on Medicare expenditures in the 1990s suggests that lower income households have began to account for higher levels of spending (Lee, McClellan, and Skinner, 1999; McClellan and Skinner, 2004. Health care expenditures have been used to construct measures of "full income" that include both money income and government-financed health care expenditures. This approach was pioneered by Eugene Smolensky and his colleagues at Wisconsin during the 1970s in the study of income distribution (Reynolds and Smolensky, 1977; Moon, 1977) , and extended to valuing health care benefits in a money-metric context . More recently, Fuchs (1998a Fuchs ( , 2001 has used this approach to document the very large fraction of full income among the elderly in the U.S. comprised of health care expenditures, most of which is paid for by younger generations. The implicit message in creating full income measures is the opportunity cost of health care
spending, that a reduction in health care spending could have a large impact on money income, particularly among low income groups.
The interest in illness-adjusted expenditures or utilization can be motivated by a concern about access to care, where the null hypothesis of perfect equality is presumably one where high income and low income individuals with similar medical ailments would be treated with the same procedures and with the same degree of intensity. But some have questioned whether equal rates of utilization are really the same as equal access, for example if people with high incomes experienced different preferences for care (Mooney et. al., 1991 , Culyer et. al., 1992 . While economists are generally comfortable taking preferences as given, the issue is less clear in the health care literature. For example, Ibrahim, et. al. (2001 Ibrahim, et. al. ( , 2002 documented more distrust of surgery among black candidates for hip or knee replacement, and placed greater reliance on alternative (nonsurgical) approaches such as copper bracelets or prayer. Katz (2001) has distinguished between preferences "guided by informed decisions" and those "limited by truncated opportunities or historical circumstances." Thus if low income households are less likely to seek care because of past adverse encounters with the health care system, their choices today may be related less to immutable preferences and more to past financial or cultural barriers in access to care.
Another shortcoming of using health expenditures is that higher levels of expenditures may not translate into better health outcomes. Glover (1938) counseled against the overuse of tonsillectomies at a time when the risk of surgical complications was high. He and his colleagues noted that children of anxious high-income parents were more likely to receive the procedure and hence more likely exposed to the risk of operative mortality. More generally, Fisher et. al. (2003a, b) has suggested that regions with greater use of health care were no more likely to experience better outcomes or even improved satisfaction of patients and access to care. In other words, higher expenditures do not always translate into better health.
In the past decade, there has been an increasing interest in the inequality of health, whether measured as lifespan, quality-adjusted life years, healthy life years, or selfreported health. 8 Measuring health outcomes avoids the problem of inferring the effectiveness of health care expenditures on outcomes. It also has the advantage of capturing income-based differences in a variety of factors such as health behavior, diet, and life-course events that have a larger impact on health outcomes than the health care system alone. The results are if anything quite a bit stronger, exhibiting a uniform and consistent gradient between income and health care outcomes.
Inequality in health outcomes can be present even in the absence of inequality in health care. Suppose that the health care system were perfectly equal, and provided instant access to all people in society. Inequality in outcomes could still occur for a variety of reasons. The first is simply luck or genetic differences across the population (Gakidou, Murray, and Frenk, 2000) . However, most summary measures of incomebased health inequality remove this source of inequality by averaging over large numbers of individuals. For example the "concentration index" compares the cumulative distribution of income on the horizontal axis, and the cumulative distribution of healthy life years (however measured) on the vertical axis, thereby averaging out variation occurring within income categories.
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The second source of lifespan inequality arises from potential differences in health behavior such as diet, smoking, exercise, drinking, and other factors associated with income and socioeconomic status, so that "... inequalities in health reflect the wider inequalities in society." (Le Grand, 1982, p. 45.) For example, Contoyannis and Jones (2004) report that these measures of "healthy living" in 1984 were strong predictors of positive good health in 1991. Of course, this raises the very difficult question again of how one can separate "preferences" for health-related behavior from income per se.
These health behaviors or health shocks can have long-lasting effects, for example see Almond's (2003) study of the long-term negative repercussions of being in utero during the 1918 influenza epidemic. As well, these long-term health shocks can affect both earnings capacity and health, muddying the causal link between income and health outcomes even further (Case and Deaton, 2003; Elstad and Krokstad, 2003; Graham, 2002 ).
We suggest a more restrictive but theoretically cleaner measure of health care inequality: to measure utilization rates of effective care, procedures that are efficacious for every appropriate patient. Examples include mammography screening for women aged 65-69, and blocker, aspirin, reperfusion therapies, and ACE inhibitor use for heart attack patients. 10 Mammography has been adopted as a measure of preventive care in other studies as well, for example see Decker (2004) and Card, Dobkin, and Maestas (2004) .
There are several advantages in using such measures. The first is the existence of a reliable link between utilization and health outcomes. Second, there is no need to control (however imperfectly) for health status, since among appropriate or ideal patients, nearly everyone should receive the treatment. Finally, preferences should generally not play a strong role in the use of such interventions, given that the objective benefits are so much larger than the costs. 11 Trends or levels in several of these effective care measures will be considered further below, after first examining the empirical record on the evolution of health care expenditures and survival by income group.
The Distribution of Medicare Expenditures by Zip Code Income
The Continuous Medicare History Survey (CMHS), a 5 percent sample of every lives in may better reflect permanent income than self-reported income, which may be infested with measurement error and transitory income, and particularly for the elderly population not reflect important components of household wealth. On the other hand, zip code income is subject to "ecological bias," poor Medicare enrollees in rich neighborhoods could be treated differently from rich enrollees in poor neighborhoods.
One previous study, however, has suggested that zip code income provides a reasonable characterization in health-related research (Geronimus, et. al., 1996) .
In quantifying health care expenditures for the over 65 population, we express all expenditures in 2001 dollars, and estimate age-sex-specific expenditures in 5-year age increments (plus those 85+) for each of 10 income deciles. In aggregated data, we use direct adjustment to normalize the per capital Medicare expenditures to a constant age and sex composition over time by use of the sample frequencies of the 10 age-sex categories.
12 Only fee-for-service Medicare enrollees are included in the sample, which means that expenditures made on behalf of enrollees in Medicare managed care will not be included in this sample. 13 The sample size is sufficiently large (30.8 million personyears) that standard errors are small, and so are not reported. 
The Distribution of Survival Gains by Income
We next consider overall survival gains in the Medicare population. Here the sample includes not just the fee-for-service population but also the HMO enrollees; this is to avoid potential selection bias caused by healthier individuals joining managed care organizations. We consider two different cohorts from the Continuous Medicare History
Survey. The first is the group of people age 65-69 and 75-79 alive in 1982, and the second is the corresponding group alive at age 1992. Figure 3 shows the percentage of the groups age 65-69 in the initial year who were still alive ten years later by sex and year of the cohort by income decile. There is a clear income gradient in both years; people living in higher zip code incomes were more likely to survive during both the 1980s and 1990s. A similar pattern is shown for those aged 75-79 in 1982 and 1992, detailed in Table 2 , with life expectancy rising by more for men than for women. While all groups gained in terms of survival probabilities, the highest income groups gained the most, both in percentage and in absolute terms.
To quantify these changes in terms of the change in expected survival years, we chain together the two panels of 10 year survival curves for the younger and older cohorts, and estimate the change in expected survival years for a synthetic cohort over a 20 year period (from 65-69 to 85-89) with fixed weights for men and women based on the fraction of women in the age 65-69 cohort (54.8 percent). There was a 0.2 increase in expected life years in the bottom income decile, a 0.5 increase in the 5th decile, and a 0.8 increase in the top income decile. 
Inequality in the Provision of Effective Care
Here we focus on specific measures of effective care, considering first mammography rates among women age 65-69 in the Medicare population. The advantage of using 20 Recent work has focused on placing a dollar value to increased survival, see Becker, Philipson, and Soares (2003) or Berloffa, Brugiavini, and Rizzi (2003) . A different approach to quantifying the changes over time in survival is the concentration index, a variant of a Gini coefficient (Contoyannis and Forster, 1999) . However, changes in the index were very small since we were just considering inequality in the over 65 population and not over the entire life-course.
mammography rates is that we have a time-series on rates of screening from [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] and so can measure changes over time in screening rates. A 5% sample of Part B physician claims data is used from 1993-1997, and a 20% sample from 1998-2001. The later 20% sample also includes hospital outpatient data as separate from physician-based claims, these would include women who were screened for example in a hospital-based clinic. In theory, not including such outpatient records for all years could bias our results if low income women were more likely to receive care in an outpatient setting. In practice, as we show using data from 1998-2001, the bias is small or non-existent. and 1998. This was the consequence of removing the $100 coinsurance payment on January 1, 1998 and allowing reimbursement for annual rather than biannual screening.
It is surprising that rates for all income groups appear to have risen by about the same amount, given that low income households should have been most sensitive to the relaxation of the $100 copayment.
Similar results for 1998-2001 were also found in comparing rates of screening for eye examinations among patients with diabetics. These examinations check for damage to the vascular system caused by high uncontrolled blood glucose levels (available upon request from the authors). While encompassing a shorter time period, there was similarly no evidence of trends in the income-based gradient of screening for diabetic eye examinations.
Of course, some part of the income-based differential could be the consequence of noncompliance; that is that lower income patients don't sign up or show up for their screening appointment. We therefore consider physician directives or procedures performed in the first few days following acute myocardial infarction, where the primary goal of the physician is to keep the patient alive, and patient preferences and noncompliance issues should play a small role. The measures of effective care for heart attack patients are derived from the Cooperative Cardiovascular Project (CCP) survey of more than 160,000 AMI patients over age 65 in 1994/95. The survey information included detailed clinical data from chart reviews along with information on how the patient was treated. This allowed clinical researchers to determine from the chart data patients who were "ideal" or appropriate for the use of the specific treatment; thus the right rate should be a number near 100 percent, regardless of health status, income, age, or any other characteristic. For this reason, we do not control for covariates or health indices, but consider simple averages by income decile. Table 4 presents income-based differences in utilization of effective care along with the total sample size in the bottom row. Approximate 95% confidence intervals are presented at the bottom of the table; these apply to each of the means in the column because the deciles ensure equal sample sizes and the exact binomial confidence intervals are based on the average ratio. Table 4 suggests that in 1994/95, utilization of these measures were remarkably low. For example, the use of Blockers was less than half of appropriate patients when the target rates should have been closer to 100 percent. Second, rates of use for effective care were modestly elevated among higher income groups; for example in Blockers, rates ranged from 40 percent in the bottom income decile to 47 percent in the top decile.
Indeed, for some treatments, such as ACE inhibitors used to control hypertension, there were no income-based difference in utilization.
One additional question is whether high income individuals are more likely to receive higher quality care because of treatment differences within regions, or because they are more likely to live in regions where overall effective care rates are higher (Chandra and Skinner, 2003) . In Figure 5 utilization rates for Blockers are estimated with and without categorical regional variables. First, the previous results are replicated in a logistics regression coefficients converted to percentage screening rates. State dummy variables are then introduced and the logistics regression is re-estimated, again with odds ratios converted to probabilities, and shown in Figure 5 . The adjusted probability of Blocker use holding constant the state of residence shows just a 3.6 percentage point difference by income group rather than a 7 percentage point difference.
(In this latter regression, only the 8 th and 10 th decile coefficients were significantly different from zero.) That is, half of the income gradient here is the consequence of where patients live and not how patients are treated within regions. The result does not generalize, however. A similar analysis for mammography screening and diabetic eye exams during 1998-2001 did not suggest any diminution in the effects of income on utilization rates after controlling for region of residence.
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In theory, we would like to know how the income gradient in Blocker use evolved over time, but we have just one observation from the survey in 1994/95. Since the use of Blockers for heart attack patients were rare before the early 1980s, we may safely infer that the observed difference in 1994/95 reflects a somewhat higher growth rate in the use of Blockers among the top income deciles, at least through 1994/95.
Since then, compliance has improved, but in 2001 median compliance is still less than 70 percent (Jencks, 2003) . It is possible that rates of compliance have risen more rapidly in low income regions, but Alabama was low in the use of Blockers in 1994/95 and it remained relatively low in 2001.
Conclusions and Discussion
How should one judge whether inequality in health has improved or worsened during the past several decades? This paper has considered several alternative approaches to measuring inequality using US data from the elderly Medicare population over age 65. While Medicare expenditures grew much more rapidly among the lowest income deciles, health outcomes improved much less rapidly for this group. Economists and health services researchers have long recognized the distinction between inequality in health care (as measured by expenditures) and inequality in health (as measured by survival), beginning at least with Victor Fuchs' comparison of Nevada and Utah, two states with similar health care expenditures but very different mortality rates (Fuchs, 1998b) .
We suggest a different approach to measuring inequality that relies on effective care, or measures of health care quality. For these measures, efficacy is well proven and nearly all of the relevant population should be receiving it, regardless of health status or preferences. A examination of the past decade suggests that there has been little or no relative improvement in the utilization of effective care measures among lower income deciles. Thus the discordance between rapidly rising health expenditures of low income households and rapidly rising longevity of high income households is not quite so puzzling.
It should be cautioned that the magnitudes of the differences in effective care observed in the data would not be expected to exert a large impact on overall mortality rates. The predicted impact on heart attack patients of a 7 percentage point increase in blocker use (i.e., the difference between the top and bottom income decile rate of use) is a 0.21 percentage point decline in mortality, or an overall impact on the general population of about 0.01 percent since just 5 percent of the Medicare population experience a heart attack in any year. 22 The fact that these measures of effective care account for a small fraction of overall expenditures, and a small fraction of the overall variation in health outcomes, motivates interest in other measures of quality, for example with regard to the overuse of marginally effective procedures (Fisher, et. al., 2003a,b) . 22 The 0.21 percent shift is derived by multiplying 7 percentage points times the implied 3 percentage point reduction in one-year mortality estimated by using an odds ratio (estimated for 30 day mortality) of 0.88 reported in Heidenrich and McClellan (2001) .
There are three important limitation of this study. The first is that in using outcome data, we have focused only on survival and not quality-adjusted or "healthy life years." To capture a more full measure of health, it would be necessary to include income-based differentials in treatments with proven effectiveness but for improving functioning rather than survival per se. Examples include hip or knee replacements for the treatment of osteoarthritis or the use of angioplasty for patients with ischemic heart disease. However, measuring true income-based differences in health status is more difficult, given the necessity of adjusting for differential health needs (i.e., rates of osteoarthritis of the hip by income group) and for preferences (however defined) regarding surgical intervention.
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Second, the study is limited to just the over-65 population. Focusing just on income-based differences in mammography rates within the Medicare program ignores the fact that Medicare itself contributes to a substantial increase in mammography rates at age 65 among those previously uncovered by insurance or in lower educational groups (Decker, 2004; Card, Dobkin, and Maestas, 2004) . Focusing just on inequality within a specific age group ignores changes in inequality across age groups, for example differences between those under age 65 who are increasingly lacking health insurance, and those over age 65 who are generally covered (Danziger, Haveman, and Smolensky, 1977) .
Finally, we have not considered the financing side of the Medicare program.
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